Clinical Trial Update: Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal Neurostimulator [NA]

View source ↗

Summary

Six-month study assessing the safety and effectiveness of the intranasal lacrimal neurostimulator; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome
• Keratoconjunctivitis Sicca

Drugs mentioned

• Intranasal Lacrimal Neurostimulator

Snippet

Sponsor: Oculeve, Inc. | Conditions: Dry Eye Syndromes, Keratoconjunctivitis Sicca | NA | Status: COMPLETED | Results posted: 2017-10-31